Form 4: NEXGEL Director Scott Robert Henry Sells 3,000 Shares Under 10b5-1 Trading Plan

Director Scott Robert Henry sold 3,000 shares of NEXGEL, INC. common stock at an average price of $3.3655 per share under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On January 7, 2025, Scott Robert Henry, a director of NEXGEL, INC., sold 3,000 shares of common stock.
• The sale was executed at a weighted average price of $3.3655 per share, with individual transactions ranging from $3.31 to $3.62.
• The transaction was conducted under a Rule 10b5-1 trading plan.
• Following the sale, Henry directly owns 141,553 shares of NEXGEL, INC.
• The shares sold were originally purchased in the open market on September 16, 2022.

Sentiment

Score: 5

Explanation: The document is a neutral report of an insider transaction. The use of a 10b5-1 plan suggests the sale was pre-planned and doesn't necessarily reflect a negative outlook on the company.

Industry Context

This Form 4 filing is a routine disclosure of insider trading activity. It provides transparency into the transactions of company insiders, allowing investors to monitor potential alignment or misalignment of interests between management and shareholders. The use of a 10b5-1 trading plan suggests the sale was pre-planned and not based on any material non-public information.

Stakeholder Impact

• The sale of shares by a director could have a minor negative impact on shareholder sentiment, although the use of a 10b5-1 plan mitigates this concern.

Key Dates